We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
-20.41%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$864M
AUM Growth
-$127M
Cap. Flow
+$112M
Cap. Flow %
12.95%
Top 10 Hldgs %
81.94%
Holding
45
New
1
Increased
11
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$78.9M
2
ASML icon
ASML
ASML
+$11.3M
3
NVDA icon
NVIDIA
NVDA
+$7.56M
4
QRVO icon
Qorvo
QRVO
+$6.22M
5
AMD icon
Advanced Micro Devices
AMD
+$5.38M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$18.3M

Sector Composition

Rank Sector Weight
1 Communication Services 51.63%
2 Healthcare 17.75%
3 Consumer Discretionary 14.57%
4 Technology 11.74%
5 Industrials 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNYA icon
26
Tenaya Therapeutics
TNYA
$161M
$3.79M 0.44%
673,270
– –
RKLB icon
27
Rocket Lab Corp
RKLB
$43.7B
$3.79M 0.44%
1,000,000
– –
GBIO
28
DELISTED
Generation Bio
GBIO
$3.35M 0.39%
51,035
– –
TNGX icon
29
Tango Therapeutics
TNGX
$4.44B
$3.21M 0.37%
708,385
– –
AFRM icon
30
Affirm
AFRM
$25.5B
$3.13M 0.36%
173,560
– –
CFLT
31
DELISTED
Confluent
CFLT
$3.03M 0.35%
130,383
– –
SANA icon
32
Sana Biotechnology
SANA
$882M
$3.01M 0.35%
468,749
– –
SRZN icon
33
Surrozen
SRZN
$255M
$2.43M 0.28%
55,123
– –
FULC icon
34
Fulcrum Therapeutics
FULC
$282M
$2.01M 0.23%
410,714
– –
PRAX icon
35
Praxis Precision Medicines
PRAX
$8.51B
$1.91M 0.22%
51,901
– –
PCTTW
36
PureCycle Technologies Inc Warrant
PCTTW
$10.6M
$1.89M 0.22%
714,285
– –
DBTX
37
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$1.38M 0.16%
328,798
– –
PRDS
38
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.23M 0.14%
400,000
– –
XLO icon
39
Xilio Therapeutics
XLO
$60.3M
$1.22M 0.14%
29,719
– –
PACB icon
40
Pacific Biosciences
PACB
$441M
$1.01M 0.12%
229,144
– –
VIGL
41
DELISTED
Vigil Neuroscience
VIGL
$747K 0.09%
289,460
– –
DYN icon
42
Dyne Therapeutics
DYN
$4.7B
$737K 0.09%
107,252
– –
MCRB icon
43
Seres Therapeutics
MCRB
$49.1M
$452K 0.05%
6,592
– –
IRON icon
44
Disc Medicine
IRON
$2.92B
$423K 0.05%
8,333
– –
DNTH icon
45
Dianthus Therapeutics
DNTH
$5.74B
$399K 0.05%
20,788
– –
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return

Harvard Management Company's Q2 2022 Portfolio in Review

As of Q2 2022, Harvard Management Company held 45 positions worth $864M, down 13% from $991M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Harvard Management Company deployed $112M of net new capital in Q2 2022, opening 1 new position and adding to 11 existing holdings. Its largest new stake was ASML: 20,186 shares worth $9.61M.

By sector, the portfolio is most concentrated in Communication Services at 52% of assets, down from 52% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $18.3M trimmed.

  • Harvard Management Company's largest Q2 2022 buy was ASML: 20,186 shares worth $9.61M.
  • Harvard Management Company added most to Alphabet (Google) Class A in Q2 2022, an estimated $78.9M increase.
  • Harvard Management Company's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $18.3M.
  • Harvard Management Company's ten largest holdings make up 82% of its $864M portfolio in Q2 2022.
  • Harvard Management Company opened 1 new position and closed 0 in Q2 2022.
  • Harvard Management Company's portfolio value fell 13% quarter-over-quarter to $864M.

Based on Harvard Management Company's 13F filing for Q2 2022, filed 12 Aug 2022.